Canada will cut prices but avoid tenders

Prices of nearly 70 commonly-prescribed generics in Canada will see their prices cut by between 25% and 40% from 1 April 2018, under a new five-year initiative that has been agreed between the pan-Canadian Pharmaceutical Alliance (pCPA) and the Canadian Generic Pharmaceutical Association (CGPA) for participating federal, provincial and territorial public drug plans.